Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129


Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study.

Traby L, Kollars M, Eischer L, Eichinger S, Kyrle PA.

PLoS One. 2012;7(12):e51447. doi: 10.1371/journal.pone.0051447. Epub 2012 Dec 11.


Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.

Krzek M, Ciesla-Dul M, Zabczyk M, Undas A.

Thromb Res. 2012 Oct;130(4):e216-21. doi: 10.1016/j.thromres.2012.08.302. Epub 2012 Aug 30.


Age at first venous thromboembolism and risk of recurrence: a prospective cohort study.

Eischer L, Eichinger S, Kyrle PA.

Medicine (Baltimore). 2009 Nov;88(6):366-70. doi: 10.1097/MD.0b013e3181c29e31.


Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.

Meltzer ME, Lisman T, Doggen CJ, de Groot PG, Rosendaal FR.

PLoS Med. 2008 May 6;5(5):e97. doi: 10.1371/journal.pmed.0050097.


Superficial thrombophlebitis and risk for recurrent venous thromboembolism.

Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Partsch H, Eichinger S.

J Vasc Surg. 2003 Apr;37(4):834-8.


The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study.

Eischer L, Eichinger S, Kyrle PA.

J Thromb Haemost. 2014 May;12(5):635-40. doi: 10.1111/jth.12528.


Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009. Review.


Sex-specific risk factors for recurrent venous thromboembolism.

Olié V, Zhu T, Martinez I, Scarabin PY, Emmerich J.

Thromb Res. 2012 Jul;130(1):16-20. doi: 10.1016/j.thromres.2011.10.026. Epub 2011 Nov 17.


The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.

Arch Intern Med. 2002 Nov 11;162(20):2357-60.


Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.

Sonnevi K, Tchaikovski SN, Holmström M, Rosing J, Bremme K, Lärfars G.

Thromb Haemost. 2011 Nov;106(5):901-7. doi: 10.1160/TH11-04-0254. Epub 2011 Sep 22.


Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time.

Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA.

J Thromb Haemost. 2006 Apr;4(4):752-6.


Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis.

Karasu A, Baglin TP, Luddington R, Baglin CA, van Hylckama Vlieg A.

Br J Haematol. 2016 Mar;172(6):947-53. doi: 10.1111/bjh.13911. Epub 2016 Jan 15. Review.


Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.

Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S.

Circulation. 2003 Jul 22;108(3):313-8. Epub 2003 Jul 7.


The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.


Overweight, obesity, and the risk of recurrent venous thromboembolism.

Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O, Heinze G, Kyrle PA.

Arch Intern Med. 2008 Aug 11;168(15):1678-83. doi: 10.1001/archinte.168.15.1678.


Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.

Undas A, Zawilska K, Ciesla-Dul M, Lehmann-Kopydłowska A, Skubiszak A, Ciepłuch K, Tracz W.

Blood. 2009 Nov 5;114(19):4272-8. doi: 10.1182/blood-2009-05-222380. Epub 2009 Aug 18.


The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.

Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Minar E, Lechner K, Kyrle PA.

Thromb Haemost. 1997 Apr;77(4):624-8.


Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.

Kearon C, Julian JA, Kovacs MJ, Anderson DR, Wells P, Mackinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M, Ginsberg JS; ELATE Investigators.

Blood. 2008 Dec 1;112(12):4432-6. doi: 10.1182/blood-2008-06-163279. Epub 2008 Sep 12.


Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer.

Eichinger S, Hron G, Kollars M, Kyrle PA.

Clin Chem. 2008 Dec;54(12):2042-8. doi: 10.1373/clinchem.2008.112243. Epub 2008 Oct 23.

Supplemental Content

Support Center